Help: RFA for Parkinson's Disease?

Dan Jacobson danj at dev.gdb.org
Wed Oct 20 15:06:28 EST 1993


In article <16C689D02.SHICKLEY at VM.TEMPLE.EDU> SHICKLEY at VM.TEMPLE.EDU writes:
>Organization: Temple University
>X-Newsreader: NNR/VM S_1.3.2
>
>Does anyone know of any Parkinson's-specific RFAs from NIH that are
>current? I haven't seen any in the NIH Guide to which I subscribe and
>my attempts to locate info in the NIH electronic database has not
>been fruitful. If you know of an RFA number, I would be most
>appreciative, as I wouldn't want to launch a proposal into an
>inappropriate study section.

A little gophering finds a few - I've tried to include some useful 
excerpts below - at least of those that specifically mention  Parkinson's.

Let me know if you've never heard of gopher and want a little help getting 
started.

Best of luck,

Dan Jacobson

danj at mail.gdb.org

---------------------------------------------------------------------------
---------------------------------------------------------------------------

92.01.24 PA

NEUROLOGICAL MOTOR CONTROL AND MOTOR CONTROL DISORDERS:  RESTITUTION
OF FUNCTION

NIH GUIDE, Volume 21, Number 3, Part II of II, January 24, 1992

PA:  PA-92-36

P.T. 34

....

RESEARCH GOALS AND SCOPE

This announcement is issued to encourage and foster
investigator-initiated basic, clinical, and applied research on motor
control and its disorders.  Examples of research objectives
appropriate for inclusion in applications responsive to this PA
include:

.....

o  Studies of the neurological dysfunctions in motor control
associated with cerebellar degeneration, hereditary ataxias,
demyelinating disorders, such as multiple sclerosis, and in
degenerative disorders such as Huntington's and Parkinson's disease;

---------------------------------------------------------------------------
---------------------------------------------------------------------------

92.11.20 PA

VULNERABILITY OF THE OLFACTORY SYSTEM TO THE IMPACT OF ENVIRONMENTAL
TOXICANTS AND PATHOGENS

NIH GUIDE, Volume 21, Number 42, November 20, 1992

PA:  PA-93-24

P.T. 34

....

Research Goals and Scope

The ultimate goal of this research program to develop targeted drug
delivery, vector-based vaccines, and other interventions for the
treatment and prevention of the effects of toxic agents on the
olfactory system.  Collaboration is encouraged between investigators
within and outside of the field of olfaction, including inhalation
toxicologists, virologists, immunologists, and molecular biologists.
A broad range of studies extending from the molecular to the behavioral
levels of basic and clinical research is applicable to this
Announcement.  Topics might include some of those listed below.
Investigators are encouraged to consider other topics relevant to this
program.

.....

o  Olfactory abnormalities induced by toxic agents as early signs of
neurodegenerative diseases, such as Alzheimer's disease and
Parkinson's disease.


---------------------------------------------------------------------------
---------------------------------------------------------------------------

93.08.06 RFP-RFA

HUMAN FETAL TISSUE CHARACTERIZATION FOR TRANSPLANTATION

NIH GUIDE, Volume 22, Number 28, August 6, 1993

RFA AVAILABLE:  HD-94-006

P.T. 34

.....

RESEARCH OBJECTIVES

The use of human fetal tissue transplants has been advocated for
several years as a means of treating a number of devastating
diseases.  Fetal tissue transplants may allow replacement of tissues
and cell products that have been damaged, destroyed, or that never
developed properly due to disease or a genetic disorder.  These
maladies are life threatening unless intervention is instituted.

Childhood diseases such as inborn errors of metabolism, immune
deficiencies and other entities are being considered for very early
treatment using fetus-to-fetus transplants.  Diseases such as
insulin-dependent diabetes mellitus (IDDM) and Parkinson's Disease
are also prospective candidates for transplantation therapy.



More information about the Neur-sci mailing list